We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

142 hedge funds and large institutions have $727M invested in Aerie Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 45

10% less funds holding

Funds holding: 158 → 142 (-16)

12% less capital invested

Capital invested by funds: $830M → $727M (-$104M)

17% less call options, than puts

Call options by funds: $281K | Put options by funds: $337K

52% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 31

Holders
142
Holders Change
-16
Holders Change %
-10.13%
% of All Funds
2.47%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
59
Reduced
45
Closed
31
Calls
$281K
Puts
$337K
Net Calls
-$56K
Net Calls Change
+$1.2M

Top Buyers

Rank Fund Capital Flow
1
William Blair Investment Management
William Blair Investment Management
Illinois
+$9.41M
2
LCS
Levin Capital Strategies
New York
+$7.48M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$6.48M
4
DM
Deerfield Management
New York
+$5.69M
5
MGIM
M&G Investment Management
United Kingdom
+$4.89M

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$29.8M
2
RCMNY
Rubric Capital Management (New York)
New York
-$8.59M
3
CS
Candriam SCA
Luxembourg
-$7.48M
4
NHAS
Novo Holdings A/S
Denmark
-$4M
5
BlackRock
BlackRock
New York
-$3.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$6.86M +$1.14M +66,692 +18%
WP
27
Woodline Partners
California
$6.71M -$29.8M -1,737,899 -81%
Principal Financial Group
28
Principal Financial Group
Iowa
$6.7M -$1.9M -110,742 -21%
IHAM
29
Integral Health Asset Management
New York
$6.56M +$1.03M +60,000 +17%
FCM
30
Frontier Capital Management
Massachusetts
$6.56M -$386K -22,494 -5%
ACM
31
Atika Capital Management
New York
$6.33M -$1.45M -84,500 -18%
Renaissance Technologies
32
Renaissance Technologies
New York
$5.88M +$2.4M +139,863 +61%
Charles Schwab
33
Charles Schwab
California
$5.05M +$289K +16,851 +6%
NAM
34
Nexpoint Asset Management
Texas
$4.96M -$1.5M -87,220 -22%
GIP
35
Granite Investment Partners
California
$4.8M -$667K -38,894 -11%
Two Sigma Advisers
36
Two Sigma Advisers
New York
$4.67M +$2.92M +170,400 +140%
DCM
37
DAFNA Capital Management
California
$4.63M +$226K +13,200 +5%
AGA
38
Altrinsic Global Advisors
Connecticut
$3.84M – – –
Goldman Sachs
39
Goldman Sachs
New York
$3.73M +$240K +13,969 +6%
VOYA Investment Management
40
VOYA Investment Management
Georgia
$3.38M -$113K -6,574 -3%
Millennium Management
41
Millennium Management
New York
$3.31M +$2.26M +131,748 +176%
Macquarie Group
42
Macquarie Group
Australia
$3.09M – – –
Bank of New York Mellon
43
Bank of New York Mellon
New York
$3.03M -$423K -24,648 -12%
Fidelity Investments
44
Fidelity Investments
Massachusetts
$2.98M -$2.32K -135 -0.1%
Two Sigma Investments
45
Two Sigma Investments
New York
$2.9M -$892K -52,011 -22%
EWM
46
Endurance Wealth Management
Rhode Island
$2.84M +$855K +49,859 +39%
HA
47
Homestead Advisers
Virginia
$2.43M – – –
Voloridge Investment Management
48
Voloridge Investment Management
Florida
$2.31M +$47K +2,740 +2%
Allianz Asset Management
49
Allianz Asset Management
Germany
$2.18M -$281K -16,355 -11%
JAMONY
50
Jacob Asset Management of New York
California
$2.07M +$789K +46,000 +55%
1
2
3 4 5

AERI Hedge Fund Activity: Q2 2021 in Review

142 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q2 2021, worth a combined $727M — down 12% from $830M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of AERI and 15 opened new positions — a net loss of 16 holders — while 45 trimmed existing stakes and 59 added.

The largest buyer was William Blair Investment Management, adding an estimated $9.41M. The largest seller was Woodline Partners, cutting an estimated $29.8M.

  • 142 institutional investors held Aerie Pharmaceuticals (AERI) as of Q2 2021, down from 158 in Q1 2021.
  • Funds reported $727M of Aerie Pharmaceuticals stock for Q2 2021, down 12% quarter-over-quarter.
  • 15 funds opened new Aerie Pharmaceuticals positions in Q2 2021 and 31 closed out, a net change of -16 holders.
  • The largest Aerie Pharmaceuticals buyer in Q2 2021 was William Blair Investment Management, an estimated $9.41M added.
  • The largest Aerie Pharmaceuticals seller in Q2 2021 was Woodline Partners, an estimated $29.8M sold.

Based on aggregated 13F filings for Q2 2021.